title: Glaxo's AZT announcement welcomed, but detail is yet to follow. mother-to-child transmission.
authors.forename: H
authors.initials: H
authors.lastname: Worthington
mesh_terms: D000163:Acquired Immunodeficiency Syndrome; D003132:Commerce; D003365:Costs and Cost Analysis; D003906:Developing Countries; D004194:Disease; D004467:Economics; D015658:HIV Infections; D007221:Industry; D018445:Infectious Disease Transmission, Vertical; D007390:International Agencies; D007391:International Cooperation; D008389:Marketing of Health Services; D009938:Organizations; D004364:Pharmaceutical Preparations; D013812:Therapeutics; D014480:United Nations; D014777:Virus Diseases
chemical_list: D004364:Pharmaceutical Preparations
keywords: Acquired Immunodeficiency Syndrome--prevention and control; Commerce; Commercial Sector; Developing Countries; Diseases; Drugs; Economic Factors; Hiv Infections--prevention and control; Industry; International Agencies; International Cooperation; Macroeconomic Factors; Marketing; Organizations; Pricing; Treatment; Un; Vertical Transmission--prevention and control; Viral Diseases